NSEOutcome of Board Meeting6d ago · 27 Aug 2026, 05:26 pm
Outcome of Board Meeting
Laxmi Dental Limited · LAXMIDENTL
✦ AI SummaryResults
Laxmi Dental Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2026, where the Board of Directors approved allotment of 7,911 Equity Shares to eligible employees under Laxmi Dental Stock Option Scheme 2024, proposed variation in the objects of the Initial Public Offering proceeds, and closure of trading window.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Laxmi Dental Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2026.
Attachments (1)
📄pdf
Download →
LAXMI_27082026172557_Outcome.pdf
View document text
Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058.
Tel: 022 61437991 | Email: info@laxmidentallimited.com | Website: www.laxmidentallimited.com
CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL
Date: August 27, 2026
Listing Department Listing & Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Mumbai – 400001 Plot No. C/1, “G” Block
BSE Scrip Code: 544339 Bandra-Kurla Complex
Bandra (E), Mumbai – 400 051
Symbol: LAXMIDENTL
Dear Sir(s)/Madam(s),
Re: LAXMI DENTAL LIMITED - ISIN: INE0WO601020
Subject: Outcome of Board Meeting held today i.e. Thursday, August 27, 2026.
Ref: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Pursuant to the Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended from time to time (“SEBI Listing Regulations”), we wish to inform you that the Board of
Directors, at its meeting held today i.e., Thursday, August 27, 2026, inter-alia, has considered and approved the following:
1. Approved allotment of 7,911/- (Seven Thousand Nine Hundred and Eleven only) Equity Shares of face value of
INR 2/- (Rupees Two only) each, to the eligible employees of the Company and its subsidiaries, pursuant to
exercise of the options vested with them under Laxmi Dental Stock Option Scheme 2024 (“ESOP
2024”/”Scheme”).
Consequent to the aforesaid allotment, the paid-up equity share capital of the Company stands increased as below:
Pre-Allotment Post Allotment
No. of Equity Shares Face value (in ‘INR’) No. of Equity Shares Face value (in ‘INR’)
held held
5,50,21,509 2 5,50,29,420 2
The details and disclosures as required under the Regulation 10(c) SEBI (Share Based Employee Benefits and Sweat
Equity) Regulations, 2021 are enclosed as Annexure – 1 of this letter.
2. Proposed variation in the objects of the Initial Public Offering (“IPO”) proceeds and extension of timeline for
utilization of IPO proceeds (“Proposed Variation”), subject to approval of shareholders’ approval.
The details of the Proposed Variation are enclosed herewith as Annexure 2.
The Company will make the applicable disclosure upon issuance of the notice for obtaining shareholders’ approval
for the proposed variation in the objects and extension of the timeline for utilization of IPO proceeds in due course.
Further details of the Proposed Variation will be provided in the explanatory statement attached to the notice.
Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058.
Tel: 022 61437991 | Email: info@laxmidentallimited.com | Website: www.laxmidentallimited.com
CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL
3. Closure of Trading Window
Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, and
in terms of the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading
window for dealing in securities of the Company shall remain closed for all Designated Persons, Connected Persons and their
immediate relatives from Thursday, August 27, 2026 till 48 hours after the declaration of voting results of the Shareholders’
Meeting (Annual General Meeting) in view of the proposed variation in the objects and extension of the timeline for
utilization of IPO proceeds, both of which are subject to the approval of the Shareholders of the Company.
The aforesaid closure of the trading window is being communicated to the Designated Persons, their immediate relatives and
connected persons in accordance with the Company’s Code of Conduct for Prohibition of Insider Trading.
The meeting of the Board of Directors commenced at 04:00 P.M. (IST) and concluded at 04:30 P.M. (IST).
The same will be made available on the Company’s website, i.e. www.laxmidentallimited.com
Kindly take the same on your record.
For Laxmi Dental Limited
--------------------------------------------------
Suman Saha
Company Secretary and Compliance Officer
ICSI Membership Number: A33035
Encl.: As above.
Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058.
Tel: 022 61437991 | Email: info@laxmidentallimited.com | Website: www.laxmidentallimited.com
CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL
Annexure – 1
Statement as per the format prescribed in Part E of Schedule – I under Regulation 10(c) of (Share Based Employee Benefits
and Sweat Equity) Regulations, 2021
1. Company name and address of Name: Laxmi Dental Limited
Registered Office: CIN: L51507MH2004PLC147394
Registered office Address: Office No. 103, Akruti Arcade, J.P. Road,
Opposite A.H. Wadia High School, Andheri West, Mumbai-400058,
Maharashtra.
2. Name of the recognised Stock BSE Limited (“BSE”) and
Exchanges on which the company's National Stock Exchange of India Limited (“NSE”)
shares are listed:
3. Filing date of the statement referred Stock Exchange Date of filing Date of approval
in regulation 10(b) of the Securities application
and Exchange Board of India (Share
Based Employee Benefits and Sweat BSE 12.01.2026 10.04.2026
Equity) Regulations, 2021 with the
NSE 12.01.2026 08.04.2026
recognised Stock Exchange:
4. Filing Number, if any : BSE: 256958
NSE: 52967
5. Title of the Scheme pursuant to Laxmi Dental Stock Option Scheme 2024 (“ESOP 2024”/”Scheme”)
which shares are issued, if any:
6. Kind of security to be listed: Equity Shares
7. Par value of the shares: INR 2/- per share
8. Date of issue of shares: August 27, 2026
9. Number of shares issued: 7,911 Equity Shares
10. Share Certificate No., if applicable: Not Applicable
11. Distinctive number of the share, if 5,50,21,510 - 5,50,29,420
applicable:
12. ISIN Number of the shares if issued INE0WO601020
in Demat:
13. Exercise price per share: INR 2 per share
14. Premium per share : NA
15. Total issued shares after this issue : 5,50,29,420 Equity Shares
16. Total issued share capital after this INR 11,00,58,840/-
issue:
17. Details of any lock-in on the shares : Not applicable
18. Date of expiry of lock-in : Not applicable
19. Whether shares are identical in all All equity shares of the Company allotted pursuant to exercise of
respects to existing shares? If not, stock options shall rank pari-passu with the existing equity shares of
when will they become identical? : the Company
20. Details of listing fees, if payable : Not applicable
Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058.
Tel: 022 61437991 | Email: info@laxmidentallimited.com | Website: www.laxmidentallimited.com
CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL
Annexure – 2
The details of the Proposed Variation are set out in the table below:
(in INR million)
Sr. Objects of the IPO Total Money Amount Details of Revised Balance Revised
No. amount utilized unutilized variation amount post timeline
raised for the as on after Proposed for
object August 18, Proposed Variation utilization
2026 Variation
Original objects of the IPO as stated in the Prospectus
1. Repayment/prepayment, 229.84 229.84 - No change - - -
in full or in part, of certain
outstanding borrowings
availed by our Company
2. Investment in certain 46.00 46.00 - No change - - -
Subsidiaries for the
repayment/prepayment,
in full or in part, of certain
outstanding borrowings
3. Funding the capital 435.07 177.81 257.26 Funds NIL NIL -
expenditure reallocated
requirements for to newly
purchase of new added
machinery for our object
Company
4. *Investment in our 250.04 26.27 223.77 Funds NIL NIL -
Subsidiary, Bizdent reallocated
Devices Private Limited, to newly
for the capital added
expenditure object
requirements for the
purchase o
[Showing first 8,000 characters — download PDF for full document]